Kinnate Biopharma Inc.

NasdaqGS:KNTE Stock Report

Mkt Cap: US$332.6m

Kinnate Biopharma Company Information

Kinnate Biopharma Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Kinnate Biopharma Inc.
  • Ticker: KNTE
  • Exchange: NasdaqGS
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$332.560m
  • Shares outstanding: 44.16m
  • Website:

Number of Employees


  • Kinnate Biopharma Inc.
  • 103 Montgomery Street
  • Suite 150
  • San Francisco
  • California
  • 94129
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6KBMUN (Boerse Muenchen)YesCommon StockDEEURDec 2020
KNTENasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/02/01 00:00
End of Day Share Price2023/01/31 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.